{"abstract":"The National Institute of Child Health and Human Development, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the U.S. and foreign Patents and Patent Applications listed in the Supplementary Information section of this notice to Panacea Opportunity, Ltd.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2021/06/24/2021-13261.html","cfr_references":[],"citation":"86 FR 33321","comment_url":null,"comments_close_on":"2021-07-09","correction_of":null,"corrections":[],"dates":"Only written comments and/or applications for a license which are received by the National Institute of Child Health and Human Development c/o National Cancer Institute's Technology Transfer Center on or before July 9, 2021 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2021-13261","effective_on":null,"end_page":33322,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2021/06/24/2021-13261.xml","html_url":"https://www.federalregister.gov/documents/2021/06/24/2021-13261/prospective-grant-of-an-exclusive-patent-license-delivery-of-a-corrective","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2021-13261?publication_date=2021-06-24","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2021-06-24/2021-13261/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":143,"last_updated":"2026-06-25 04:15:03 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2021-06-24/pdf/2021-13261.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2021-13261.pdf?1624452338","publication_date":"2021-06-24","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2021/06/24/2021-13261.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2023-02-28T22:32:04Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":33321,"subtype":null,"title":"Prospective Grant of an Exclusive Patent License: Delivery of a Corrective Glucose-6-Phosphatase-Alpha Gene to Treat Glycogen Storage Disease Type 1a (GSD-Ia) in Humans","toc_doc":"Delivery of a corrective glucose6phosphatasealpha gene to treat glycogen storage disease type 1a in humans.","toc_subject":"Prospective Grant of an Exclusive Patent License:\n","topics":[],"type":"Notice","volume":86}